Correlation between function and proto-oncogene expression in isolated working rat hearts under various overload conditions

Journal of Molecular and Cellular Cardiology

Volumn 29, Issue 11, 1997, Pages 2903-2914

  Horban, Andreas ^b   Kolbeck Rühmkorff, Claudia ^b   Zimmer, Heinz Gerd ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b NONE

Author keywords

c fos mRNA; c myc mRNA; Cardiac hypertrophy; Heart failure; Norepinephrine; Pressure overload; Proto oncogenes; Volume overload; Working rat heart preparation

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA;

ANIMAL TISSUE; AORTA FLOW; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DENSITOMETRY; GENE EXPRESSION; HEART AFTERLOAD; HEART FUNCTION; HEART LEFT ATRIUM PRESSURE; HEART OUTPUT; HEART PERFUSION; HEART PRELOAD; HEART VENTRICLE OVERLOAD; HEART VOLUME; ISOLATED HEART; MALE; NONHUMAN; NORTHERN BLOTTING; ONCOGENE C FOS; ONCOGENE C MYC; PRIORITY JOURNAL; RAT;

EID: 0031281413     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1997.0525     Document Type: Article

References (48)

1. AMATI B, LITTLEWOOD TD, EVAN GI, LAND H, 1993. The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max. EMBO J 12: 5083-5087.
2. BARKA T, VAN DER NOEN H, SHAW PA, 1987. Proto-oncogene fos (c-fos) expression in the heart. Oncogene 1: 439-443.
3. BING OHL, 1994. Hypothesis: apoptosis may be a mechanism for the transition to heart failure with chronic pressure overload. J Mol Cell Cardiol 26: 943-948.
4. BIRNBOIM HC, 1988. Rapid extraction of high molecular weight RNA from cultured cells and granulocytes for Northern analysis. Nucleic Acids Res 16: 1487-1497.
5. BISHOP JM, 1991. Molecular themes in oncogenesis. Cell 64: 235-248.
6. BLACKWOOD EM, EISENMAN RN, 1991. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251: 1211-1217.
7. BÜNGER R, HADDY FJ, QUERENGÄSSER A, GERLACH E, 1975. An isolated guinea pig heart preparation with in vivo like features. Pflügers Arch 353: 317-326.
8. CURRAN T, FRANZA BR, 1988. Fos and Jun: AP-1 connection. Cell 55: 395-397.
9. CURRAN T, PETERS G, VAN BEVEREN C, TEICH NM, VERMA IM, 1982. FBJ murine osteosarcoma virus: identification and molecular cloning of biologically active proviral DNA. J Virol 44: 674-682.
10. CURRAN T, MACCONNELL WP, VAN STRAATEN F, VERMA IM, 1983. Structure of the FBJ murine osteosarcoma virus genome: molecular cloning of its associated helper virus and the cellular homolog of the v-fos gene from mouse and human cells. Mol Cell Biol 3: 914-921.
11. CURRAN T, MILLER AD, ZOKAS L, VERMA IM, 1984. Viral and cellular fos proteins: a comparative analysis. Cell 36: 259-268.
12. DANG CV, 1991. c-Myc oncoprotein function. Biochim Biophys Acta 1072: 103-113.
13. DENIS N, BLANC S, LEIBOVITCH MP, NICOLAIEW N, DAUTRY F, RAYMONDJEAN M, KRUH J, KITZIS A, 1987. c-Myc oncogene expression inhibits the initiation of myogenic differentiation. Exp Cell Res 172: 212-217.
14. FINKEL MP, BISKIS BO, JINKINS PB, 1966. Virus induction of osteosarcomas in mice. Science 151: 698-701.
15. 1. Nature 328: 445-449.
16. HOLT JT, GOPAL TV, MOULTON AD, NIENHUIS AW, 1986. Inducible production of c-fos antisense RNA inhibits 3T3 cell proliferation. Proc Natl Acad Sci USA 83: 4794-4798.
17. IWAKI K, SUKHATME VP, SHUBEITA HE, CHIEN KR, 1990. α- and β-Adrenergic stimulation induces distinct patterns of immediate early gene expression in neonatal rat myocardial cells. J Biol Chem 265: 13809-13817.
18. JACKSON T, ALLARD MF, SREENAN CM, DOSS LK, BISHOP SP, SWAIN JL, 1990. The c-myc proto-oncogene regulates cardiac development in transgenic mice. Mol Cell Biol 10: 3709-3716.
19. KOLBECK-RUHMKORFF C, ZIMMER H-G, 1995. Proto-oncogene expression in the isolated working rat heart: combination of pressure and volume overload with norepinephrine. J Mol Cell Cardiol 27: 501-511.
20. KOLBECK-RUHMKORFF C, HORBAN A, ZIMMER H-G, 1993. Effect of pressure and volume overload on proto-oncogene expression in the isolated working rat heart. Cardiovasc Res 27: 1998-2004.
21. KOMURO I, KURABAYASHI M, TAKAKU F, YAZAKI Y, 1988. Expression of cellular oncogenes in the myocardium during the developmental stage and pressure-over-loaded hypertrophy of the rat heart. Circ Res 62: 1075-1079.
22. LAND H, PARADA LF, WEINBERG RA, 1983. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304: 596-602.
23. LANGENDORFF O, 1895. Untersuchungen am überlebenden Säugethierherzen. Pflügers Arch Ges Physiol 61: 291-332.
24. LIU Z, HILBELINK DR, CROCKETT WB, GERDES AM, 1991. Regional changes in hemodynamics and cardiac myocyte size in rats with aortocaval fistulas. 1. Developing and established hypertrophy. Circ Res 69: 52-58.
25. MANIATIS T, FRITSCH EF, SAMBROOK J, 1982. Molecular Cloning. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
26. MOALIC JM, BAUTERS C, HIMBERT D, BERCOVICI J, MOUAS C, GUICHENEY P, BAUDOIN-LEGROS M, RAPPAPORT L, EMANOIL-RAVIER R, MEZGER V, SWYNGHEDAUWB, 1989. Phenylephrine, vasopressin and angiotensin II as determinants of proto-oncogene and heat-shock protein gene expression in adult rat heart and aorta. J Hypertens 7: 195-201.
27. MOALIC JM, MOAZAMI-GOUDARZI K, THIEM NV, DELCAYRE C, BERCOVICI J, MOUAS C, SWYNGHEDAUW B, 1992. Hormonal induction of c-fos and HSP68 mRNAs on an isolated coronary perfused adult rat heart. Arch Int Physiol Biochim Biophys 100: 165-170.
28. MORGAN HE, NEELY JR, WOOD RE, LIÉBECQ C, LIEBERMEISTER H, PARK CR, 1965. Factors affecting glucose transport in heart muscle and erythrocytes. Fed Proc 24: 1040-1045.
29. MÜLLER R, 1986. Cellular and viral fos genes: structure, regulation of expression and biological properties of their encoded products. Biochim Biophys Acta 823: 207-225.
30. NEELY JR, LIEBERMEISTER H, BATTERSBY EJ, MORGAN HE, 1967. Effect of pressure development on oxygen consumption by isolated rat heart. Am J Physiol 212: 804-814.
31. OBERBÄUMER I, 1992. Retroposons do jump: a B2 element recently integrated in an 18S rDNA gene. Nucleic Acids Res 20: 671-677.
32. RENZ M, NEUBERG M, KURZ C, BRAVO R, MÜLLER R, 1985. Regulation of c-fos transcription in mouse fibroblasts: identification of DNase I-hypersensitive sites and regulatory upstream sequences. EMBO J 4: 3711-3716.
33. RÜTHER U, MÜLLER W, SUMIDA T, TOKUHISA T, RAJEWSKY K, WAGNER EF, 1988. c-fos expression interferes with thymus development in transgenic mice. Cell 53: 847-856.
34. SCHAPER J, HEIN S, ELSÄSSER A, SCHOLZ D, DEVAUX B, CAI W-J, 1996. Degeneration, apopotosis and necreosis -the response to chronic heart disease of various causes. J Mol Cell Cardiol 28: S1-3, A299 (Abstract).
35. SCHNEIDER A, ZIMMER H-G, 1991. Effect of inosine on function and adenine nucleotide content of the isolated working rat heart: studies of postischemic reperfusion. J Cardiovasc Pharmacol 7: 466-473.
36. SCHNEIDER MD, PAYNE PA, UENO H, PERRYMAN MB, ROBERTS R, 1986. Dissociated expression on c-myc and a fos-related competence gene during cardiac myogenesis. Mol Cell Biol 6: 4140-4143.
37. SCHUNKERT H, JAHN L, IZUMO S, APSTEIN CS, LORELL BH, 1991. Localization and regulation of c-fos and c-jun protooncogene induction by systolic wall stress in normal and hypertrophied rat hearts. Proc Natl Acad Sci USA 88: 11480-11484.
38. 1 adrenergic response. J Clin Invest 72: 732-738.
39. STARKSEN NF, SIMPSON PC, BISHOPRIC N, COUGHLIN SR, LEE WMF, ESCOBEDO JA, WILLIAMS LT, 1986. Cardiac myocyte hypertrophy is associated with c-myc protooncogene expression. Proc Natl Acad Sci USA 83: 8348-8350.
40. VAN BEVEREN C, VAN STRAATEN F, CURRAN T, MÜLLER R, VERMA IM, 1983. Analysis of FBJ-MuSV provirus and c-fos (mouse) gene reveals that viral and cellular fos gene products have different carboxy termini. Cell 32: 1241-1255.
41. WALLENSTEIN S, ZUCKER CL, FLEISS JL, 1980. Some statistical methods useful in circulation research. Circ Res 47: 1-9.
42. ZIERHUT W, ZIMMER H-G, 1989. Significance of myocardial α- and β-adrenoceptors in catecholamine-induced cardiac hypertrophy. Circ Res 65: 1417-1525.
43. ZIERHUT W, ZIMMER H-G, GERDES AM, 1991. Effect of angiotensin converting enzyme inhibition on pressure-induced left ventricular hypertrophy in rats. Circ Res 69: 609-617.
44. ZIMMER H-G, 1983. Normalization of depressed heart function in rats by ribose. Science 220: 81-82.
45. ZIMMER H-G, 1984. Correlation between haemodynamic and metabolic changes in three models of experimental cardiac hypertrophy. Eur Heart J 5 (Suppl. F): 171-179.
46. ZIMMER H-G, STEINKOPFF G, GERLACH E, 1972. Changes in protein synthesis in the hypertrophying rat heart. Pflügers Arch 336: 311-325.
47. ZIMMER H-G, IBEL H, SUCHNER U, 1990. β-Adrenergic agonists stimulate the oxidative pentose phosphate pathway in the rat heart. Circ Res 67: 1525-1534.
48. ZIMMER H-G, HECKMANN M, LORTET S, 1993. Cardiovascular response to triiodothyronine in Sprague-Dawley and spontaneously hypertensive rats. Cardioscience 4: 157-162.